Subclinical Myocardial Dysfunction in Pediatric and Adolescent Celiac Disease Patients: A Systematic Review and

Elpida Emmanouilidou-Fotoulaki1, Maria Kavga2, Michail Delis3

  • 11st Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.

Insights

Children with celiac disease may have early myocardial dysfunction, detectable by echocardiography. A gluten-free diet did not significantly improve these cardiac markers in this systematic review.

Area of Science:

  • Pediatric Cardiology
  • Gastroenterology
  • Systematic Reviews

Background:

  • Celiac disease is an autoimmune disorder affecting the small intestine.
  • Early detection of subclinical myocardial dysfunction in pediatric celiac disease is crucial.
  • The impact of a gluten-free diet on cardiac function in these patients requires investigation.

Purpose of the Study:

  • To systematically review and meta-analyze early echocardiographic markers of myocardial function in children and adolescents with celiac disease.
  • To compare cardiac function between celiac patients and healthy controls.
  • To assess the effect of gluten-free diet adherence on myocardial function.

Main Methods:

  • Systematic literature search across major electronic databases.
  • Inclusion of 15 studies involving 916 pediatric celiac disease patients and 569 healthy controls.
  • Analysis of conventional and advanced echocardiographic parameters, including fractional shortening and myocardial performance index.

Main Results:

  • A trend toward reduced myocardial function was observed in celiac disease patients across various echocardiographic parameters.
  • Statistical significance was noted in fractional shortening and myocardial performance index.
  • No significant improvement in these cardiac parameters was found after adherence to a gluten-free diet.

Conclusions:

  • Routine cardiovascular examination using echocardiography is recommended for children with celiac disease to detect subclinical myocardial dysfunction.
  • The myocardial performance index shows potential as a non-invasive marker for assessing cardiac function in this population.
  • Further research is needed to confirm the reliability and clinical applicability of echocardiographic markers and to evaluate long-term effects of gluten-free diet compliance.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
497
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812